>I22207.1 Sequence 21 from patent US 5527671
CACCAGGTGA
>I22206.1 Sequence 20 from patent US 5527671
GCGCGGCACT
>I22205.1 Sequence 19 from patent US 5527671
CGGCGTTACG
>I22204.1 Sequence 18 from patent US 5527671
GAGAACTGGC
>I22203.1 Sequence 17 from patent US 5527671
ATGGATGACG
>I22202.1 Sequence 16 from patent US 5527671
GTCGCCTGAG
>I22201.1 Sequence 15 from patent US 5527671
CCGGCTTATG
>I22200.1 Sequence 14 from patent US 5527671
CCCATGGCCC
>I22199.1 Sequence 13 from patent US 5527671
GTACATGGGC
>I22198.1 Sequence 12 from patent US 5527671
CCCATGGCCC
>I22197.1 Sequence 11 from patent US 5527671
CGGACCGCGT
>I22196.1 Sequence 10 from patent US 5527671
AACGGGCACC
>I22195.1 Sequence 9 from patent US 5527671
GCTGGTTGGA
>I22194.1 Sequence 8 from patent US 5527671
ACAGGCAGAC
>I22193.1 Sequence 7 from patent US 5527671
AGCGCCGACG
>I22192.1 Sequence 6 from patent US 5527671
GGGGGCCTCA
>I22191.1 Sequence 5 from patent US 5527671
CGGGGCGGAA
>I22190.1 Sequence 4 from patent US 5527671
ACCGTGCGTC
>I22189.1 Sequence 3 from patent US 5527671
GCATGGTAGC
>I21909.1 Sequence 28 from patent US 5525488
CTCGAGCTGG
>I21707.1 Sequence 3 from patent US 5523389
GGGGGTTTTT
>I21706.1 Sequence 2 from patent US 5523389
GGGTTTTGGG
>I21680.1 Sequence 12 from patent US 5523221
GAAGTCCTTC
>I21679.1 Sequence 11 from patent US 5523221
GAANNNNTTC
>I21632.1 Sequence 24 from patent US 5523217
TCNGGCCTAC
>I21631.1 Sequence 23 from patent US 5523217
TCMGGCCTAC
>I21630.1 Sequence 22 from patent US 5523217
TCNGGCCTAC
>I21620.1 Sequence 12 from patent US 5523217
GNCATCNGGC
>I21619.1 Sequence 11 from patent US 5523217
GNCATCMGGC
>I21618.1 Sequence 10 from patent US 5523217
GNCATCNGGC
>I21229.1 Sequence 75 from patent US 5518901
AAGCGGCCGC
>I21220.1 Sequence 66 from patent US 5518901
CGCCGGCGAA
>I21133.1 Sequence 18 from patent US 5518885
GTGGGGGGGG
>I21132.1 Sequence 17 from patent US 5518885
GGTGGGGGGG
>I21131.1 Sequence 16 from patent US 5518885
YSSCCMNSSS
>I20923.1 Sequence 16 from patent US 5516682
AGTAAAACCA
>I20621.1 Sequence 19 from patent US 5514788
ATAGCGAGGC
>I20463.1 Sequence 42 from patent US 5514577
CACGGGGTCG
>I20458.1 Sequence 37 from patent US 5514577
GGGGTTGGGG
>I20357.1 Sequence 18 from patent US 5514568
GAGTCNNNNN
>I20351.1 Sequence 12 from patent US 5514568
GTCTCNNNNN
>I20349.1 Sequence 10 from patent US 5514568
GGATCNNNNN
>I20346.1 Sequence 7 from patent US 5514568
CTCTTCNNNN
>I20217.1 Sequence 10 from patent US 5514548
CATGCCCGGT
>I20216.1 Sequence 9 from patent US 5514548
CCGGACCGGG
>I19953.1 Sequence 18 from patent US 5512463
GAGTCNNNNN
>I19947.1 Sequence 12 from patent US 5512463
GTCTCNNNNN
>I19945.1 Sequence 10 from patent US 5512463
GGATCNNNNN
>I19942.1 Sequence 7 from patent US 5512463
CTCTTCNNNN
>I19601.1 Sequence 29 from patent US 5506348
NNNCAGGTAA
>I19170.1 Sequence 33 from patent US 5502176
TTTTCTGCCC
>I19169.1 Sequence 32 from patent US 5502176
CTACTTCTCC
>I19168.1 Sequence 31 from patent US 5502176
CTTCTGCCTC
>I19167.1 Sequence 30 from patent US 5502176
CTCTGATAGA
>I19166.1 Sequence 29 from patent US 5502176
TCCTTTGAAT
>I19165.1 Sequence 28 from patent US 5502176
TCCGCCCTCT
>I19164.1 Sequence 27 from patent US 5502176
TCACTGAGCC
>I19163.1 Sequence 26 from patent US 5502176
GGCTATGTGC
>I19162.1 Sequence 25 from patent US 5502176
GACCAGGCAG
>I19141.1 Sequence 4 from patent US 5502176
GGATCCCAGA
>I18913.1 Sequence 11 from patent US 5498831
CGGAATTCCG
>I18846.1 Sequence 27 from patent US 5498696
ATCACCCCAC
>I18329.1 Sequence 2 from patent US 5495009
ATGGTCAAGG
>I18264.1 Sequence 6 from patent US 5494814
NNNCGAAACN
>I18020.1 Sequence 255 from patent US 5494807
TCGAGGATCC
>I17850.1 Sequence 80 from patent US 5494807
AGCTTCTAGA
>I17849.1 Sequence 79 from patent US 5494807
TCGATCTAGA
>I17723.1 Sequence 3 from patent US 5494794
CCCCCTCCCC
>I17511.1 Sequence 1 from patent US 5491063
GAGACCATCA
>A35193.1 Synthetic NcoI linker
TACCATGGTA
>A35192.1 Synthetic NcoI linker
TACCATGGTA
>A34825.1 HSV oligo
GAGCAGATCC
>A34617.1 Synthetic hirudin gene variant adaptor
ATACGTACGT
>A34615.1 Synthetic hirudin gene variant adaptor
ATACGTCATG
>A32674.1 Nucleotide sequence 10 from patent number WO8800973
GATACTCCTG
>A29157.1 Synthetic linker DNA from patent DE3312928
TCCCTAGGGA
>A29156.1 Synthetic linker DNA from patent DE3312928
TCCCTAGGGA
>A28788.1 BamHI linker no.3
CGGGATCCCG
>A26616.1 BamHI-linker
CGGGATCCCG
>A26320.1 Synthetic linker for mouse perforin production
CCGGATCCGG
>A25264.1 Synthetic Ser A 1509 linker
GCTCTAGAGC
>A16127.1 Oligonucleotide adaptor (SEQ ID NO: 10)
AATTGAGCTC
>A22121.1 oligonucleotide
GGCTCAATCT
>A21621.1 oligonucleotide GA310
AATTCCCGGG
>A20085.1 oligonucleotide
CCCAGATCCG
>A19427.1 oligonucleotide
TCGACCCCCT
>A19426.1 oligonucleotide
AGCTAGGGGG
>A18263.1 oligonucleotide
CTAGAGTATG
>A18057.1 oligonucleotide
CGCCATGGCT
>A18056.1 oligonucleotide
AGCCATGGCG
>A17619.1 Nucleotide sequence 11 from patent number EP0337899
CAATGCATGC
>A17359.1 terminator sequence
AAAAACAAAA
>A17358.1 terminator sequence
TTTTGTTTTT
>A16789.1 oligonucleotide
GAATTCAGGC
>A16788.1 oligonucleotide
GCCTGAATTC
>A15678.1 oligonucleotide
CCGGATCCGG
>A15328.1 Oligonucleotide T6
TCGACAAAAA
>A15128.1 Nucleotide sequence 9 from patent number FR2595374
GATCCCGCTC
>A15125.1 Nucleotide sequence 6 from patent number FR2595374
GATCCCGGGA
>A15124.1 Nucleotide sequence 5 from patent number FR2595374
GATCCCGGGA
>A15082.1 Nucleotide sequence 8 from patent number FR2598430
CCGGATCCGG
>A15081.1 Nucleotide sequence 7 from patent number FR2598430
CATGGAGCTT
>A15080.1 Nucleotide sequence 6 from patent number FR2598430
TTCGAGGTAC
>A13780.1 oligonucleotide 19
AAAGGAGAGG
>A13779.1 oligonucleotide 18
TAAGGAGAGG
>A12813.1 synthetic linker oligonucleotide
CGATGNNNNA
>A16528.1 oligonucleotide T6
TCGACAAAAA
>A16116.1 oligonucleotide
TCGAGTTAAA
>A16115.1 oligonucleotide
GATCTTTAAC
>A15912.1 Beta-1,3-glucanase (G19-9) TCA sequence from stress-induced plant genes
TCATCTTTTC
>A15911.1 Beta-1,3-glucanase (G19-9) TCA sequence from stress-induced plant genes
CCATCTTCTC
>A15910.1 Beta-1,3-glucanase (G19-9) TCA sequence from stress-induced plant genes
TCATCTTCTT
>A15909.1 Beta-1,3-glucanase (G19-9) TCA sequence from stress-induced plant genes
TCATCTTCTT
>A15662.1 oligonucleotide
GCCACCTTCG
>A13233.1 oligonucleotide linker
GATCCCGGGA
>A13232.1 oligonucleotide linker
AGCTTCCCGG
>A13154.1 Nucleotide sequence 30 from patent number EP0299242
TCGAGTTAAA
>A13153.1 Nucleotide sequence 29 from patent number EP0299242
GATCTTTAAC
>A12698.1 inserted sequence at the unique Sma I site of PLG609
GAATTCTCTT
>A12154.1 Nucleotide sequence 6 from patent number EP0198415
CGACCATGGT
>A12153.1 Nucleotide sequence 5 from patent number EP0198415
CGACCATGGT
>A12105.1 oligonucleotide
ACAAGCTTGT
>A12104.1 oligonucleotide
ACAAGCTTGT
>A11946.1 Synthetic oligonucleotide A from patent EP0070675
TAGGATCCTA
>A11945.1 Synthetic oligonucleotide A from patent EP0070675
TAGGATCCTA
>A11770.1 Nucleotide sequence 9 from patent number EP0228018
GAATTCATGG
>A11768.1 Nucleotide sequence 7 from patent number EP0228018
CCATGAATTC
>A11723.1 Nucleotide sequence 3 from patent number EP0133282
AATTCGGGCG
>A11722.1 Nucleotide sequence 2 from patent number EP0133282
TCGACGCCCG
>A11620.1 oligonucleotide "M'"
GGAGACAACG
>A11619.1 oligonucleotide "L'"
TCTCCAAAAA
>A11613.1 oligonucleotide "F'"
TCGACAAAAA
>A11458.1 Nucleotide sequence 2 from patent number EP0093948
GTGACCCGGG
>A11457.1 Nucleotide sequence 1 from patent number EP0093948
CCCGGGTCAC
>A11439.1 Nucleotide sequence 3 from patent number EP0161504
GTCCATGGTG
>A11349.1 Nucleotide sequence 10 from patent number EP0276330
GTCCTCATAG
>A11111.1 Synthetic nucleotide adaptor
TCGAGAAAAC
>A11026.1 Nucleotide sequence 2 from patent number EP0245217
AGAATTAATT
>A11025.1 Nucleotide sequence 1 from patent number EP0245217
AATTAATTCT
>A11022.1 Nucleotide sequence 7 from patent number EP0245130
GAANNNNTTC
>A11021.1 Nucleotide sequence 6 from patent number EP0245130
GAANNNNTTC
>A10723.1 Oligonucleotide adapter
GTCCTGCATG
>A10609.1 Oligonucleotide encoding for two arginine residues
AATTGCGCCT
>A10445.1 Oligonucleotide SO4
GATCCATCGT
>A10408.1 Oligonucleotide
CATTAGTTAT
>A10261.1 Synthetic nucleotide sequence fragment encoding part of the glucagon polypeptide residues within pMT290
CTTGAGAGTG
>A10177.1 Nucleotide sequence 4 from patent number EP0011560
AATTCCCCAG
>A09357.1 Nucleotide sequence 7 from patent number EP0220679
CCCCGAATTC
>A07834.1 Human immunodeficiency virus type 1 env gene
AACTAAAGAA
>A06493.1 reverse complement
AAGCTTGCAG
>A06492.1 Nucleotide sequence 20 from patent number EP0126546
CTGCAAGCTT
>A04966.1 Nucleotide sequence 11 from patent number EP0142268
ACGTGGATGA
>A03679.1 Nucleotide sequence 7 from patent number EP0225860
CCGAATTCGG
>A03673.1 Nucleotide sequence 1 from patent number EP0225860
CCGAATTCGG
>A10387.1 oligonucleotide
AGCTTAAACC
>A09790.1 reverse complement
GATCCTCATG
>A09789.1 Nucleotide sequence 13 from patent number EP0369413
AATTCATGAG
>A08947.1 Nucleotide sequence 16 from patent number EP0374503
GACGTCTCCC
>A08946.1 Nucleotide sequence 15 from patent number EP0374503
GGAGCCTACC
>A08945.1 Nucleotide sequence 14 from patent number EP0374503
GGGACTTTCC
>A08944.1 Nucleotide sequence 11 from patent number EP0374503
GGGACTTTCC
>A08943.1 H.sapiens factor recognition motif in promoter
GGCCTTTCCC
>A08942.1 M.musculus factor recognition motif in promoter
GAGATTCCAC
>A08941.1 M.musculus factor recognition motif in promoter
GGTGTTTCAT
>A08940.1 M.musculus factor recognition motif in promoter
GAGATTCCAC
>A08939.1 H.sapeins factor recognition motif in promoter
GGATTTTCCC
>A08938.1 H.sapeins factor recognition motif in promoter
GAATCCCACC
>A08937.1 H.sapeins factor recognition motif in promoter
GGAATCTCCC
>A08936.1 H.sapeins factor recognition motif in promoter
GGATTTCACC
>A07050.1 Nucleotide sequence 6 from patent number EP0256424
GTCATTTCGA
>A06980.1 Nucleotide sequence 10 from patent number EP0248637
GATCCGAGAT
>A06766.1 Nucleotide sequence 8 from patent number EP0118617
AGTAGGTGCA
>A06427.1 Artificial sequence for Hind III linker, duplicate
AGAAGCTTCT
>A06372.1 Nucleotide sequence 15 from patent number EP0139076
GAGGAGAAGA
>A04826.1 Oligodeoxynucleotide
CTAGATCTAG
>A04820.1 Nucleotide sequence 8 from patent number EP0143081
GAAGACACTG
>A04694.1 EcoRI linker
CCGAATTCGG
>A04678.1 PGK
ATATAAAACA
>A04493.1 Nucleotide sequence 7 from patent number WO8400380
CCAAGCTTGG
>A04489.1 Oligonucleotide A, reverse complement
TAGGATCCTA
>A04488.1 Oligonucleotide A
TAGGATCCTA
>A04487.1 Oligonucleotide
CCAAGCTTGG
>A04352.1 Nucleotide sequence 1 from patent number WO8304051
GAATTCTATG
>A03997.1 Nucleotide sequence 2 from patent number EP0110791
GTACACTGCA
>A06426.1 Artificial sequence for Bam HI linker, duplicate
CCGGATCCGG
>A05335.1 Synthetic NarI restriction site
AGGCGCCGGT
>A04343.1 Artificial sequence mRNA human calcitonin protein, reverse complement
CCAAGCTTGG
>A04342.1 Oligonucleotide
CCAAGCTTGG
>A04328.1 Oligonucleotide
TAGGATCCTA
>A04226.1 Nucleotide sequence 38 from patent number WO8403712
TTGATCAATG
>A04225.1 Nucleotide sequence 37 from patent number WO8403712
TTGATCAATG
>A04192.1 HindIII linker
CCAAGCTTGG
>A03850.1 Oligonucleotide
CGATATCATG
>A02773.1 Nucleotide sequence 2 from patent number EP0256302
CTTAACTAGA
>A01981.1 Artificial sequence for Hind III linker
AGAAGCTTCT
>A01980.1 Artificial sequence for Bam HI linker
CCGGATCCGG
>A01527.1 Nucleotide sequence of enhancer sequence motif
ACCACCGGGT
>A01526.1 Nucleotide sequence of enhancer sequence motif
GTCATGTGGC
>A01525.1 Nucleotide sequence of enhancer sequence motif
AGCAGCTGGC
>A01524.1 Nucleotide sequence of enhancer sequence motif
TCAAGATGGC
>A01523.1 Nucleotide sequence of enhancer sequence motif
TNATTTGCAT
>A01522.1 Nucleotide sequence of enhancer sequence motif
GGGGCGGGGC
>A01521.1 Nucleotide sequence of enhancer sequence motif
ATGCAAATNA
>A01520.1 Nucleotide sequence of enhancer sequence motif
GTGTGGAAAG
>A00110.1 Nucleotide sequence 12 from patent number GB2180539
CGTCGTCAAC
>I17365.1 Sequence 15 from patent US 5487985
GGGCAGGANG
>I16222.1 Sequence 48 from patent US 5475096
TTGAGATACA
>I16037.1 Sequence 1 from patent US 5474796
ATTCTTGTTA
>I15899.1 Sequence 49 from patent US 5472840
NNNNTYNNNN
>I15876.1 Sequence 26 from patent US 5472840
GTGTGTGTGT
>I15860.1 Sequence 10 from patent US 5472840
CCCCTGANGA
>I15854.1 Sequence 4 from patent US 5472840
NNNNTMNNNN
>I15584.1 Sequence 21 from patent US 5468851
TGGTTCTGNN
>I15568.1 Sequence 5 from patent US 5468851
CANNNNNTGG
>I15192.1 Sequence 9 from patent US 5460949
CCGGATCCGG
>I13976.1 Sequence 55 from patent US 5443965
AGAAGAAGAA
>I13948.1 Sequence 27 from patent US 5443965
AAAAAAAAAA
>I13518.1 Sequence 10 from patent US 5437697
TGGTCTCTGA
>I13517.1 Sequence 9 from patent US 5437697
TCGTCACTGA
>I13516.1 Sequence 8 from patent US 5437697
CTGATACGGA
>I13515.1 Sequence 7 from patent US 5437697
GCAAGTAGCT
>I13514.1 Sequence 6 from patent US 5437697
CACATGCTTC
>I13513.1 Sequence 5 from patent US 5437697
CTCATGCATC
>I13512.1 Sequence 4 from patent US 5437697
CTCTTGCTAC
>I13511.1 Sequence 3 from patent US 5437697
CTGATGCTAC
>I13510.1 Sequence 2 from patent US 5437697
TCTCGATGCA
>I13509.1 Sequence 1 from patent US 5437697
TCCTAGCCAA
>I12911.1 Sequence 14 from patent US 5429939
GCAGTTGGCT
>I13449.1 Sequence 52 from patent US 5436156
TCGACCCCCT
>I13448.1 Sequence 51 from patent US 5436156
AGCTAGGGGG
>I13126.1 Sequence 5 from patent US 5434049
AGATTTGCAT
>I12340.1 Sequence 29 from patent US 5422262
AGCGGCCGCT
>I11797.1 Sequence 2 from Patent US 5414077
TCCAGTGATT
>I12079.1 Sequence 3 from patent US 5420027
AGGAGGTCAT
>I12028.1 Sequence 12 from Patent US 5418153
GTATTTAATG
>I12013.1 Sequence 5 from Patent US 5418150
GCGCCGGCGG
>I11406.1 Sequence 1 from Patent US 5405747
AATGGCACTG
>A01306.1 Nucleotide sequence 2 from patent number WO8600620
GAAGAACTCC
>A00933.1 Nucleotide sequence 33 from patent number WO9003437
GGTGGTACCG
>A00490.1 Nucleotide sequence 9 from patent number WO9003437
GGTGGTACCG
>L32910.1 Artificial gene sequence (L4 RNA) corresponding to G131-C143 of p2Sp1 RNA, stem loop and autocleavage site
GCGAACACGC
